Jared M. Freedberg
Consigliere Generale presso INTERCEPT PHARMACEUTICALS, INC.
Profilo
Jared M.
Freedberg is currently working as the General Counsel at Intercept Pharmaceuticals, Inc. and as the Secretary & General Counsel at Arvinas, Inc. He previously worked as the Secretary & General Counsel at Immunomedics, Inc. from 2018 to 2020.
Prior to that, he held the position of Vice President-Business Development & Strategy at Labcorp Drug Development, Inc. from 2014 to 2016 and Vice President-Legal & Business Development at Mallinckrodt LLC from 2016 to 2018.
Mr. Freedberg completed his undergraduate studies at the University of Pennsylvania and obtained his graduate degree from Duke University School of Law.
Posizioni attive di Jared M. Freedberg
| Società | Posizione | Inizio |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Consigliere Generale | 11/01/2021 |
| ARVINAS, INC. | Consigliere Generale | 16/01/2024 |
Precedenti posizioni note di Jared M. Freedberg
| Società | Posizione | Fine |
|---|---|---|
| IMMUNOMEDICS, INC. | Consigliere Generale | 01/12/2020 |
Mallinckrodt LLC
 Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Mallinckrodt LLC is proud to be one of the world's largest suppliers of both controlled substance pain medication and acetaminophen and to have over a century of leadership in helping to diagnose disease through imaging procedures. They are focused on innovative research and development programs, strong clinician relationships and a collaborative approach to new business opportunities. In short, they aim to lead a new generation of patient care by pursuing better, safer, more cost effective ways of diagnosing and treating disease to improve patient outcomes. | Consigliere Generale | 01/09/2018 |
| COVANCE INC. | Corporate Officer/Principal | 01/11/2016 |
Formazione di Jared M. Freedberg
| University of Pennsylvania | Undergraduate Degree |
| Duke University School of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| ARVINAS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Mallinckrodt LLC
Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Mallinckrodt LLC is proud to be one of the world's largest suppliers of both controlled substance pain medication and acetaminophen and to have over a century of leadership in helping to diagnose disease through imaging procedures. They are focused on innovative research and development programs, strong clinician relationships and a collaborative approach to new business opportunities. In short, they aim to lead a new generation of patient care by pursuing better, safer, more cost effective ways of diagnosing and treating disease to improve patient outcomes. | Health Technology |
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Borsa valori
- Insiders
- Jared M. Freedberg
